Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 29 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 8440689

    Fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted May 14, 2013 · Expires May 9, 2033

    granted

  2. US 8436043

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted

  3. US 8436187

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted

  4. US 8436200

    Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4- iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione and intermediates thereof

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted

  5. US 8435995

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted

  6. US 8426461

    Orally dispersible tablet

    Takeda Pharmaceutical Company Limited · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  7. US 8420694

    Pyrrolidin-2-one derivatives as androgen receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  8. US 8420816

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  9. US 8415368

    Acid secretion inhibitor

    Takeda Pharmaceutical Company Limited · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  10. US 8410087

    Indole compound

    Takeda Pharmaceutical Company Limited · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  11. US 8410089

    Fused heterocyclic ring compound

    Takeda Pharmaceutical Company Limited · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  12. US 8404643

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  13. US 8399449

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  14. US 8383647

    Quinoline derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  15. US 8362211

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  16. US 8361968

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  17. US 8354411

    1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound

    Takeda Pharmaceutical Company Limited · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  18. US 8349886

    Nitrogenated 5-membered heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  19. US 8349879

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  20. US 8344135

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  21. US 8337896

    Drug-containing nanoparticles

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  22. US 8338461

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  23. US 8338622

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  24. US 8338462

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.